Evidence map›Paper›PMID 28436946›Full record

ArticleOncogene2017

Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins.

A Antignani, D Segal, N Simon, R J Kreitman, D Huang, D J FitzGerald

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

A AntignaniLaboratory of Molecular Biology, CCR, NCI, National Institutes of Health, Bethesda, MD, USA.
D SegalCancer and Haematology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
N SimonLaboratory of Molecular Biology, CCR, NCI, National Institutes of Health, Bethesda, MD, USA.
R J KreitmanLaboratory of Molecular Biology, CCR, NCI, National Institutes of Health, Bethesda, MD, USA.
D HuangCancer and Haematology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
D J FitzGeraldLaboratory of Molecular Biology, CCR, NCI, National Institutes of Health, Bethesda, MD, USA.
National Institutes of Health · USUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Development of Recombinant Toxins to Treat Hematologic MalignanciesZIABC010301 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KREITMAN, ROBERT · 2009 to 2025
$21.7M
Bio-Therapies for the Treatment of Cancer and Infectious DiseaseZIABC008757 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FITZGERALD, DAVID · 2009 to 2025
$21.0M
TARGETED THERAPIES FOR TREATMENT OF CANCER AND AIDSZ01BC008757 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FITZGERALD, DAVID · 1997 to 2008
$1.9M
Intramural NIH HHS Z01 BC008757
6 · The paper itself

Abstract

Protein synthesis is crucial for regulating cell homeostasis and, when unrestricted, it can lead to tumorigenesis. Immunotoxins derived from Pseudomonas exotoxin are antibody-toxin fusion proteins that inhibit protein synthesis of mammalian cells via ADP-ribosylation of the eukaryotic elongation factor-2. Here we investigate the role of the Bcl-2 family proteins in the response of cancer cells to immunotoxin challenge. Besides the well-known reduction of the prosurvival Bcl-2 family member, Mcl-1, following inhibition of protein synthesis, we show for the first time that immunotoxins also reduce the levels of selected proapoptotic BH-3-only proteins. Among these, only Bim protein levels correlated with the ability of immunotoxins to induce an apoptotic response. To support our findings, we verified that a Bim knockout completely abolished immunotoxin-mediated apoptosis. Further, mice bearing either wild-type or Bid knockout tumors responded to immunotoxin treatment with a decrease in growth kinetics, whereas mice engrafted with Bim knockout tumors showed no reduction in tumor size or prolongation of survival following immunotoxin treatment. From these results, we conclude that Bim expression is a major susceptibility factor for tumor cell death and, as such, constitutes a potential biomarker that could be evaluated before immunotoxin treatment. In support of this hypothesis, clinically, we analyzed patient cells before immunotoxin treatment and report that samples of hairy cell leukemia with high levels of Bim protein responded with a greater decrease in leukemic cell count compared with those samples expressing a low level of Bim.

Indexed as

AnimalsApoptosisBcl-2-Like Protein 11CaspasesCell Line, TumorFemaleGene Knockout TechniquesHCT116 CellsHumansImmunotoxinsMiceMice, NudeNeoplasmsProtein Synthesis InhibitorsXenograft Model Antitumor AssaysBcl-2-Like Protein 11CaspasesImmunotoxinsProtein Synthesis Inhibitors

Identifiers

PMID28436946
PMCPMC11302550
OpenAlexW2609180848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.